With a substantial number of patients suffering from chronic pain, Collegium is committed to developing and commercializing a portfolio of products that address the growing problems associated with
DETERx technology can be used with drugs that are commonly abused such as opioids and amphetamines, as well as drugs that have a narrow therapeutic index that would benefit from protection against misuse such as breaking, crushing, grinding, or dissolving the product. The DETERx technology platform is covered by U.S. and international patents and patent applications.
Collegium’s lead product candidate, Xtampza ER™, is an